| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.094 | 0.06 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.081 | 0.06 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.06 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.06 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.07 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.07 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.07 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.29 | 0.07 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.078 | 0.07 |